MSG Studios contributed to a round that led by Spark Capital that boosted the digital sports media platform's valuation to about $100m.

The liver disease diagnostics spinout has secured the first tranche of a $10m series A investment by Fosun Pharma initially announced in October 2018.

State lawmakers are considering plans to fund supports for Maryland’s cybersecurity and life sciences sectors administered by local economic development agency Tedco.

Passage Bio will develop therapies for diseases affecting the central nervous system based on research by James Wilson at Penn, after raising almost $116m in a series A round.

The environmental microbiome testing kit maker has collected capital from investors including Western Digital Capital, 3M Ventures and Agfunder in its series A round.

Amazon has led the electric truck developer's latest round, which featured existing backers likely to have included corporates Abdul Latif Jameel and Sumitomo.

Opendoor, whose shareholders include GV and SoftBank Vision Fund, is reportedly seeking $200m at a $3.7bn valuation, which would take its total funding to $1.25bn.

Passage Bio has launched to develop treatments for diseases affecting the central nervous system, after raising almost $116m in a series A round backed by Lilly Asia Ventures.

Osage University Partners has contributed to a series A round for Vor Biopharma, an oncology drug developer based on work by Siddhartha Mukherjee at Columbia University.

UBC and CDRD spinout Sitka Biopharma has now lured $5.5m in total and is readying its bladder cancer treatment for initial clinical trials.